Seeking better outcomes for patients

CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs

Learn More
 

CytRx has potential milestone/royalty payments and a subsidiary called Centurion BioPharma

CytRx may receive milestones and royalties from Orphazyme for Arimoclomol

Orphazyme – other indications

Orphazyme – other indications

Orphazyme development programs for arimoclomol

CytRx may receive milestones and royalties from ImmunityBio for aldoxorubicin

CytRx partnered Pipeline with ImmunityBio – aldoxorubicin